Wo zur Behandlung von BPH

Schonende Therapien an der Heidelberger Klinik für Prostata-Therapie

TRUS Prostata, wie die Vorbereitung

Kind code of ref document : A2. Ref document number : Country of ref document : EP. Country of ref document : JP. Country of ref document : CA. DE DEA1 de CA CAC en EP EPB1 de USB2 de. EPB1 de. JPB2 de. ARA1 de. AUA1 de. CAC de. DEA1 de. PEA1 de. TWA de. UYA1 de. WOA2 de. Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof.

USB2 en. Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis. CAC en. MXA es. PEA1 es. KRB1 ko.

Verfahren zur trocknung von bibw, seiner salze und fester pharmazeutischer formulierungen mit diesem wirkstoff. Verwendung von AlphaAdrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von benigner Prostatahyperplasie.

Kombinationspräparate zur Behandlung von Funktionsstörungen des niederen Harnleiters. Bicyclische Heterocyclen, diese Verbingungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung. Chinazoline, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung.

Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung. Chinazolinderivate, diese verbindungen enthaltende arzneimittel, deren wo zur Behandlung von BPH und wo zur Behandlung von BPH zu ihrer herstellung. GBD0 en. EPA1 de. WOA1 en. ZAB en. TWB en. USB1 en. WOA2 en. DET2 de. N- 4- 3-chlorofluoro-phenylamino 3-morfolinyl-propoxy -chinazolinyl -akrylamid, ein irreversibler tyrosin-kinasen hemmer.

ILD0 en. USA1 en. Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them.

NZA en. MYA en. Stable polymorph of n- 3-ethynylphenyl -6, 7-bis 2-methoxyethoxy quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof. BRA pt. Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion. JPWOA1 ja. Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases. Wo zur Behandlung von BPH, pharmaceutical compositions containing these compounds, their use and processes for preparing them.

JPA ja. TWIB en. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them. Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for wo zur Behandlung von BPH preparation thereof.

Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them. Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation.

EPA2 de. TWA en. ARA1 es. JPB2 ja. AUA1 en. UYA1 es. CAA1 en. RUC2 ru. WOA3 en. MXPAA es. Metodos y composiciones novedosos que incluyen opioides y antagonistas de los mismos. RSA wo zur Behandlung von BPH. JOB1 en. TNA1 en. Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis. Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b.

AUA8 en. Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain. NOB1 no. CYT1 xx. EPB8 wo zur Behandlung von BPH. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same.

Ep: the epo has been informed by wipo that ep was designated in this application. Ref document number : Country of ref document : EP. Ref document number : Country of ref document : JP. Ref document number : Country of ref document : CA.